#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal dystrophy Ovarian cancer Phaeochromocytoma Neoplasm Gestational trophoblastic tumour Leiomyosarcoma Congenital cystic kidney disease Idiopathic intracranial hypertension Vaginal cancer Leiomyosarcoma recurrent Medulloblastoma Fibrous dysplasia of bone Prodromal Alzheimer's disease KBG syndrome Nephroblastoma More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Life with Disease Leukoencephalopathy – Basic Information Pulmonary fibrosis – Treatment Retinitis pigmentosa – Treatment Crigler-Najjar syndrome – Life with Disease Waldenstrom’s macroglobulinaemia refractory Ewing’s sarcoma recurrent Piriformis syndrome – Treatment Angelman’s syndrome SAPHO syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Golimumab Filgrastim Blu-222 Tasimelteon Danicamtiv Elvn-002-1 Celecoxib Posaconazole Barium Sulfate Bdc-1001 Vibostolimab Lolium Perenne Edoxaban SOFTISAN 378 L-Lysine Hydrochloride Ziprasidone Fludrocortisone Vixarelimab TRAZODONE HYDROCHLORIDE Indometacin Ph. Eur. More therapies…

    Learn about Your Condition

    Hepatobiliary disease Cerebellar ataxia Corneal dystrophy Cholestatic pruritus Osteoarthritis Periodontitis Cystic fibrosis Mixed dementia Meniscus operation Renal cell carcinoma Immune system disorder Hypersomnia Meningorrhagia Morning sickness Andersen-Tawil syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Multiple sclerosis

  • Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    • Nervous system disorder
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Interferon Beta-1A
    • Natalizumab
    • Ozanimod
    Belgium

  • Study on Cladribine for Patients with Multiple Sclerosis to Evaluate Brain Network Changes

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Cladribine
    Spain

  • Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Colestyramine
    • Teriflunomide
    • Frexalimab
    Austria Bulgaria Croatia Czechia Denmark France +10
Previous Page
1 … 8 9 10

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!